These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7693270)

  • 1. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supportive therapy with thrombocyte concentrates in bone marrow transplant patients].
    Höcker P; Hinterberger W; Lechner K; Wagner A; Emminger W
    Beitr Infusionther Klin Ernahr; 1987; 18():128-32. PubMed ID: 3326582
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current status and problem of platelet transfusion for hematopoietic diseases: results from a questionnaire survey].
    Kato H; Handa M; Takamoto S
    Rinsho Ketsueki; 2006 Dec; 47(12):1514-20. PubMed ID: 17233469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of HLA antibody formation in patients with hemato-oncologic diseases by using leukocyte depleted blood preparations].
    Adamzik ID; Jin J; Sachs V; Thomsen H
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):9-13. PubMed ID: 7727966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhancement of the efficacy of thrombocyte transfusion in aplastic anemia by the use of plasmapheresis].
    Mikhaĭlova EA; Savchenko VG; Pashinin AN; Kalinin NN; Zorenko VIu
    Ter Arkh; 1989; 61(7):141-2. PubMed ID: 2588133
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombocyte replacement in hematologic diseases].
    Höcker P
    Wien Klin Wochenschr; 1985 Nov; 97(22):841-7. PubMed ID: 3909651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hemorrhagic incidents in acute leukemia and bone marrow aplasia. Personal results 1974-1981].
    Huart JJ; Jouet JP; Bauters F; Goudemand M
    Nouv Rev Fr Hematol (1978); 1983; 25(4):229-33. PubMed ID: 6622249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfusion effect with platelet concentrates from various cell separators].
    Kretschmer V; Planitz C; Dietrich G; Pflüger HH
    Beitr Infusionsther; 1991; 28():204-8. PubMed ID: 1725620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
    Levin MD; de Veld JC; van der Holt B; van 't Veer MB
    Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocyte survival in blood diseases].
    Sakhibov IaD; Sagdieva NSh; Makhmudova MA; Novokshchenova LV; Bezinchuk RI; Akhmedzhanov KhA
    Ter Arkh; 1992; 64(12):48-51. PubMed ID: 1292133
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of platelet transfusions.
    Feusner J
    Am J Pediatr Hematol Oncol; 1984; 6(3):255-60. PubMed ID: 6393789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.
    Lim YA; Cho SR; Lee WG; Park JS; Kim SW
    Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences in thrombocyte substitution following bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen D; Mahmoud HK; Schmidt CG
    Beitr Infusionther Klin Ernahr; 1986; 15():165-71. PubMed ID: 3530241
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of autotransfusions of photo-modified blood in the combined treatment of hematology patients].
    Abdulkadyrov KM; Bessmel'tsev SS; Bel'chenko NA; Balashova VA
    Ter Arkh; 1992; 64(12):51-5. PubMed ID: 1292134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
    Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
    Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of clinical efficacy of platelet substitution in acute leukemia using resonance thrombography].
    Anders O; Ernst B; Hess G; Konrad H; Lakner V; Seyfarth M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):587-93. PubMed ID: 2414188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.